Long Term Debt - BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 6.44 USD -5.15%

Updated:

BioCryst Pharmaceuticals Inc
Long-Term Debt

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

BioCryst Pharmaceuticals Inc
Long-Term Debt Peer Comparison

ABBV

GILD

AMGN

VRTX

REGN

Company		Long-Term Debt	CAGR 3Y	CAGR 5Y	CAGR 10Y
	BioCryst Pharmaceuticals Inc NASDAQ:BCRX	Long-Term Debt $815.5m	CAGR 3-Years 47%	CAGR 5-Years 75%	CAGR 10-Years 39%
	Abbvie Inc NYSE:ABBV	Long-Term Debt $63.8B	CAGR 3-Years -5%	CAGR 5-Years 13%	CAGR 10-Years 16%
	Gilead Sciences Inc NASDAQ:GILD	Long-Term Debt $21.5B	CAGR 3-Years -8%	CAGR 5-Years -2%	CAGR 10-Years 10%
	Amgen Inc NASDAQ:AMGN	Long-Term Debt $60.1B	CAGR 3-Years 24%	CAGR 5-Years 15%	CAGR 10-Years 7%
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Long-Term Debt $361.5m	CAGR 3-Years -12%	CAGR 5-Years -8%	CAGR 10-Years -4%
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Long-Term Debt $2.7B	CAGR 3-Years 11%	CAGR 5-Years 31%	CAGR 10-Years 18%

See Also

Based on the financial report for Mar 31, 2024, BioCryst Pharmaceuticals Inc's Long-Term Debt amounts to 815.5m USD.

Over the last year, the Long-Term Debt growth was 9%. The average annual Long-Term Debt growth rates for BioCryst Pharmaceuticals Inc have been 47% over the past three years , 75% over the past five years , and 39% over the past ten years .

Join more than 144,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.